Meteorin-like Levels in Individuals With Periodontitis
Evaluation of Meteorin-like Levels in Individuals With Healthy and Periodontal Disease
1 other identifier
observational
60
1 country
1
Brief Summary
Metrnl has proven to be an inflammatory-related immunoregulatory cytokine and shown to play a role in the pathogenesis of human inflammatory diseases. Metrnl is highly expressed from the oral mucosa to the esophagus. Periodontitis is a chronic inflammatory disease that can start with localized inflammatory reactions created by the supporting tissues surrounding the teeth against microorganisms and then result in loss of teeth. The authors think that Metrnl may play a role in the periodontitis. The aim of this study is to compare the Metrnl, IL-1β, and IL-10 levels of healthy and periodontitis individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2020
CompletedFirst Posted
Study publicly available on registry
May 27, 2020
CompletedStudy Start
First participant enrolled
September 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 3, 2021
CompletedApril 29, 2024
April 1, 2024
5 months
May 19, 2020
April 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
IL-1β
saliva and serum levels
through study completion, an average of 6 months
Metrnl
saliva and serum levels
through study completion, an average of 6 months
IL-10 levels
saliva and serum levels
through study completion, an average of 6 months
Secondary Outcomes (3)
Plaque Index
up to 20 weeks
Probing Depth
up to 20 weeks
Bleeding on Probe
up to 20 weeks
Study Arms (3)
Healthy
Individuals with Periodontally Healthy
Gingivitis
Individuals with Gingival Inflammation
Periodontitis
Individuals with Periodontitis
Interventions
individuals' saliva samples will be collected and transferred to eppendorf tubes. Until biochemical analysis is carried out will be stored in -80ºC.
GCF samples of individuals will be collected by paper strips and transferred to eppendorf tubes. Until biochemical analysis is carried out will be stored in -80ºC.
Eligibility Criteria
Individuals will be divided into three different groups, about 20-25 people in each group.
You may qualify if:
- systemically healthy
- individuals who does not have a disease under treatment,
- individuals without regular systemic medication
You may not qualify if:
- smoking
- receiving periodontal treatment in the last 6 months
- pregnancy
- menopausal or menstrual period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ebru Sağlam
Istanbul, Eyalet/Yerleşke, 34668, Turkey (Türkiye)
Biospecimen
Gingival Crevicular Fluid and Saliva
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ayşe Toraman, Dr.
Saglik Bilimleri Universitesi
- STUDY CHAIR
Serhat Köseoğlu, assoc prof
Saglik Bilimleri Universitesi
- STUDY CHAIR
Mehmet Sağlam, assoc prof
Izmir Katip Celebi University
- STUDY CHAIR
Levent Savran, PhD
Izmir Katip Celebi University
- PRINCIPAL INVESTIGATOR
Ebru Sağlam, Dr
Saglik Bilimleri Universitesi
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator,Health Sciences University, Dentistry Faculty
Study Record Dates
First Submitted
May 19, 2020
First Posted
May 27, 2020
Study Start
September 23, 2020
Primary Completion
March 3, 2021
Study Completion
March 3, 2021
Last Updated
April 29, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share